Novartis AG Registered Shares
NOVN: XSWX (CHE)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
CHF 81.00 | Jwbdj | Rtqrbglxk |
Novartis Earnings: Slightly Disappointing Results, but No Changes to Long-Term Outlook
Wide-moat Novartis reported fourth-quarter earnings slightly below our expectations on higher-than-expected expenses, but we are not making any changes to our fair value estimate. With the stock trading at a 3-star rating, we believe the market is largely appropriately valuing the company’s growth prospects.